Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names?

Authors: Giorgina Barbara Piccoli, Gianfranca Cabiddu, Maria Rita Moio, Antioco Fois, Riccardo Cao, Ida Molfino, Ana Kaniassi, Francoise Lippi, Ludivine Froger, Antonello Pani, Marilisa Biolcati

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Choice of dialysis is context sensitive, explored for PD and extracorporeal dialysis, but less studied for haemodialysis (HD) and hemodiafiltration (HDF), both widely employed in Italy and France; reasons of choice and differences in prescriptions may impact on dialysis-related variables, particularly relevant in elderly, high-comorbidity patients.

Methods

The study involved two high-comorbidity in-hospital cohorts, treated in Centers with similar characteristics, in Italy (Cagliari) and France (Le Mans). All patients (204) agreed to participate. Stable cases on thrice-weekly dialysis, with at least 2 months follow-up were selected (180 patients, Males 59.4%, median age 71 years, vintage 4.3 years, Charlson index 9). Univariate and multivariate correlations between baseline data, HD-HDF, dialysis efficiency and nutritional markers were assessed.

Results

In Le Mans HDF was mainly chosen to increase efficiency (large surface dialysers, high convective volume; 76.3% of the patients), in Cagliari to improve tolerance (smaller surfaces, lower convective volume; 59% of patients). Kt/V was similar in HD and HDF, and in both settings(median Kt/V Daugirdas 2: 1.6); in the setting of high efficiency no correlation was found between Kt/V, BMI, urea, creatinine, n-PCR and phosphate. The relationship between Kt/V and albumin was divergent: a weak consensual increase was present in Cagliari, a decrease in Le Mans, suggesting a role of albumin losses with high convective volumes. In the multivariate analysis, after adjustment for other covariates (including comorbidity and type of treatment) low albumin level < 3.5 g/dl was highly correlated with setting of study: Le Mans (OR: 7.155 (2.955–17.324)). The multivariate analysis confirmed a role of type of treatment, with higher risk of low albumin levels in HDF (OR: 3.592 (1.466–8.801)), and of comorbidity (Charlson index> = 7 (OR: 3.153 (1.311–7.582)), MIS index> = 7 (OR: 5.916 (2.457–14.241)).

Conclusions

The different prescriptions of HD and HDF may have similar effects on dialysis efficiency, but diverging effects on crucial nutritional markers, such as albumin levels, probably more evident in high-comorbidity populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7(2):198–207. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7(2):198–207.
2.
go back to reference Manuel A, Gray B, Coulis N, Brunier G, Desson F, Paton MA, Tobe S. Designing dialysis prescriptions. Adv Perit Dial. 1996;12:136–42.PubMed Manuel A, Gray B, Coulis N, Brunier G, Desson F, Paton MA, Tobe S. Designing dialysis prescriptions. Adv Perit Dial. 1996;12:136–42.PubMed
3.
go back to reference CANUSA Peritoneal Dialysis Study Group. Canada-USA (CANUSA) multicentre study of peritoneal dialysis adequacy: description of the study population and preliminary results. Adv Perit Dial. 1992;8:88–92. CANUSA Peritoneal Dialysis Study Group. Canada-USA (CANUSA) multicentre study of peritoneal dialysis adequacy: description of the study population and preliminary results. Adv Perit Dial. 1992;8:88–92.
4.
go back to reference Quinn RR, Hux JE, Oliver MJ, Austin PC, Tonelli M, Laupacis A. Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol. 2011;22(8):1534–42.CrossRefPubMedPubMedCentral Quinn RR, Hux JE, Oliver MJ, Austin PC, Tonelli M, Laupacis A. Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol. 2011;22(8):1534–42.CrossRefPubMedPubMedCentral
5.
go back to reference Hall YN, Chertow GM. End stage renal disease. BMJ Clin Evid. 2007;2007 Hall YN, Chertow GM. End stage renal disease. BMJ Clin Evid. 2007;2007
6.
go back to reference Canaud B, Koehler K, Bowry S, Stuard S. What is the optimal target convective volume in on-line Hemodiafiltration therapy? Contrib Nephrol. 2017;189:9–16. Epub 2016 Dec 12CrossRefPubMed Canaud B, Koehler K, Bowry S, Stuard S. What is the optimal target convective volume in on-line Hemodiafiltration therapy? Contrib Nephrol. 2017;189:9–16. Epub 2016 Dec 12CrossRefPubMed
7.
go back to reference Morena M, Jaussent A, Chalabi L, et al. FRENCHIE study investigators. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int. 2017;91(6):1495–509.CrossRefPubMed Morena M, Jaussent A, Chalabi L, et al. FRENCHIE study investigators. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int. 2017;91(6):1495–509.CrossRefPubMed
8.
go back to reference Lucchi L, Fiore GB, Guadagni G, Perrone S, Malaguti V, Caruso F, Fumero R, Albertazzi A. Clinical evaluation of internal hemodiafiltration (iHDF): a diffusive-convective technique performed with internal filtration enhanced high-flux dialyzers. Int J Artif Organs. 2004;27(5):414–9.CrossRefPubMed Lucchi L, Fiore GB, Guadagni G, Perrone S, Malaguti V, Caruso F, Fumero R, Albertazzi A. Clinical evaluation of internal hemodiafiltration (iHDF): a diffusive-convective technique performed with internal filtration enhanced high-flux dialyzers. Int J Artif Organs. 2004;27(5):414–9.CrossRefPubMed
9.
go back to reference Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database Syst Rev. 2015;5:CD006258. Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database Syst Rev. 2015;5:CD006258.
10.
go back to reference Locatelli F, Karaboyas A, Pisoni RL, Robinson BM, Fort J, Vanholder R, Rayner HC, Kleophas W, Jacobson SH, Combe C, Port FK, Tentori F. Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS. Nephrol Dial Transplant 2017. doi: https://doi.org/10.1093/ndt/gfx277. [Epub ahead of print]. Locatelli F, Karaboyas A, Pisoni RL, Robinson BM, Fort J, Vanholder R, Rayner HC, Kleophas W, Jacobson SH, Combe C, Port FK, Tentori F. Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS. Nephrol Dial Transplant 2017. doi: https://​doi.​org/​10.​1093/​ndt/​gfx277. [Epub ahead of print].
11.
go back to reference Piccoli GB, Moio MR, Fois A, Sofronie A, Gendrot L, Cabiddu G, D'Alessandro C, Cupisti A. The diet and Haemodialysis dyad: three eras, four open questions and four paradoxes. A narrative review, towards a personalized, patient-centered approach. Nutrients. 2017;9(4) https://doi.org/10.3390/nu9040372. Piccoli GB, Moio MR, Fois A, Sofronie A, Gendrot L, Cabiddu G, D'Alessandro C, Cupisti A. The diet and Haemodialysis dyad: three eras, four open questions and four paradoxes. A narrative review, towards a personalized, patient-centered approach. Nutrients. 2017;9(4) https://​doi.​org/​10.​3390/​nu9040372.
13.
go back to reference Piccoli GB, Mezza E, Burdese M, Consiglio V, Vaggione S, Mastella C, Jeantet A, Maddalena E, Martina G, Gai M, Motta D, Segoloni GP, Piccoli G. Dialysis choice in the context of an early referral policy: there is room for self care. J Nephrol. 2005;18(3):267–75.PubMed Piccoli GB, Mezza E, Burdese M, Consiglio V, Vaggione S, Mastella C, Jeantet A, Maddalena E, Martina G, Gai M, Motta D, Segoloni GP, Piccoli G. Dialysis choice in the context of an early referral policy: there is room for self care. J Nephrol. 2005;18(3):267–75.PubMed
14.
go back to reference Canaud B, Bowry SK. Emerging clinical evidence on online hemodiafiltration: does volume of ultrafiltration matter? Blood Purif. 2013;35(1–3):55–62.CrossRefPubMed Canaud B, Bowry SK. Emerging clinical evidence on online hemodiafiltration: does volume of ultrafiltration matter? Blood Purif. 2013;35(1–3):55–62.CrossRefPubMed
15.
go back to reference Canaud B, Chenine L, Renaud S, Leray H. Optimal therapeutic conditions for online hemodiafiltration. Contrib Nephrol. 2011;168:28–38.CrossRefPubMed Canaud B, Chenine L, Renaud S, Leray H. Optimal therapeutic conditions for online hemodiafiltration. Contrib Nephrol. 2011;168:28–38.CrossRefPubMed
16.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
17.
go back to reference Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for Use in Patients with ESRD. Am J Kidney Dis. 2003;42:125–18.CrossRefPubMed Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for Use in Patients with ESRD. Am J Kidney Dis. 2003;42:125–18.CrossRefPubMed
18.
go back to reference Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251–63.CrossRefPubMed Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251–63.CrossRefPubMed
19.
go back to reference Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8(10):1094–8.PubMed Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8(10):1094–8.PubMed
20.
go back to reference Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176–81.CrossRefPubMed Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176–81.CrossRefPubMed
21.
go back to reference Chauhan V, Chauhan CG. Dialysis vintage could confound survival trends in ESRD patients. Am J Kidney Dis. 2014;64(1):156.CrossRefPubMed Chauhan V, Chauhan CG. Dialysis vintage could confound survival trends in ESRD patients. Am J Kidney Dis. 2014;64(1):156.CrossRefPubMed
22.
go back to reference Raja RM, Ijelu G, Goldstein M. Influence of Kt/V and protein catabolic rate on hemodialysis morbidity. A long-term study ASAIO J. 1992;38(3):M179–80.PubMed Raja RM, Ijelu G, Goldstein M. Influence of Kt/V and protein catabolic rate on hemodialysis morbidity. A long-term study ASAIO J. 1992;38(3):M179–80.PubMed
23.
go back to reference Chauveau P, Naret C, Puget J, Zins B, Poignet JL. Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor. Nephrol Dial Transplant. 1996;11(8):1568–73.CrossRefPubMed Chauveau P, Naret C, Puget J, Zins B, Poignet JL. Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor. Nephrol Dial Transplant. 1996;11(8):1568–73.CrossRefPubMed
24.
go back to reference Lindsay RM, Bergström J. Membrane biocompatibility and nutrition in maintenance haemodialysis patients. Nephrol Dial Transplant. 1994;9(Suppl 2):150–5.PubMed Lindsay RM, Bergström J. Membrane biocompatibility and nutrition in maintenance haemodialysis patients. Nephrol Dial Transplant. 1994;9(Suppl 2):150–5.PubMed
25.
go back to reference Caglar K, Hakim RM, Ikizler TA. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease. Nutr Rev. 2002;60(11):378–87.CrossRefPubMed Caglar K, Hakim RM, Ikizler TA. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease. Nutr Rev. 2002;60(11):378–87.CrossRefPubMed
26.
go back to reference Tsuchida K, Minakuchi J. Clinical benefits of predilution on-line hemodiafiltration. Blood Purif. 2013;35(Suppl 1):18–22.CrossRefPubMed Tsuchida K, Minakuchi J. Clinical benefits of predilution on-line hemodiafiltration. Blood Purif. 2013;35(Suppl 1):18–22.CrossRefPubMed
27.
go back to reference Masakane I. How to prescribe hemodialysis or hemodiafiltration in order to ameliorate dialysis-related symptoms and complications. Contrib Nephrol. 2011;168:53–63.CrossRefPubMed Masakane I. How to prescribe hemodialysis or hemodiafiltration in order to ameliorate dialysis-related symptoms and complications. Contrib Nephrol. 2011;168:53–63.CrossRefPubMed
28.
go back to reference Fournier A, Birmelé B, François M, Prat L, Halimi JM. Factors associated with albumin loss in post-dilution hemodiafiltration and nutritional consequences. Int J Artif Organs. 2015;38(2):76–82.CrossRefPubMed Fournier A, Birmelé B, François M, Prat L, Halimi JM. Factors associated with albumin loss in post-dilution hemodiafiltration and nutritional consequences. Int J Artif Organs. 2015;38(2):76–82.CrossRefPubMed
29.
go back to reference Orasan RA, Patiu IM, Anghel D, Bejan C, Iosub L, Totolici C, Pop M, Turcea C, Teodoru C, Orasan OH, Kacso IM, Gherman Caprioara M. Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration. Int Urol Nephrol. 2013;45(5):1415–22.CrossRefPubMed Orasan RA, Patiu IM, Anghel D, Bejan C, Iosub L, Totolici C, Pop M, Turcea C, Teodoru C, Orasan OH, Kacso IM, Gherman Caprioara M. Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration. Int Urol Nephrol. 2013;45(5):1415–22.CrossRefPubMed
30.
go back to reference Vega A, Quiroga B, Abad S, Aragoncillo I, Arroyo D, Panizo N, López-Gómez JM. Albumin leakage in online hemodiafiltration, more convective transport, more losses? Ther Apher Dial. 2015;19(3):267–71.CrossRefPubMed Vega A, Quiroga B, Abad S, Aragoncillo I, Arroyo D, Panizo N, López-Gómez JM. Albumin leakage in online hemodiafiltration, more convective transport, more losses? Ther Apher Dial. 2015;19(3):267–71.CrossRefPubMed
31.
go back to reference Cross J, Davenport A. Does online hemodiafiltration lead to reduction in trace elements and vitamins? Hemodial Int. 2011;15(4):509–14.CrossRefPubMed Cross J, Davenport A. Does online hemodiafiltration lead to reduction in trace elements and vitamins? Hemodial Int. 2011;15(4):509–14.CrossRefPubMed
32.
go back to reference Ikizler TA. Using and interpreting serum albumin and prealbumin as nutritional markers in patients on chronic dialysis. Semin Dial. 2014;27(6):590–2.CrossRefPubMed Ikizler TA. Using and interpreting serum albumin and prealbumin as nutritional markers in patients on chronic dialysis. Semin Dial. 2014;27(6):590–2.CrossRefPubMed
Metadata
Title
Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names?
Authors
Giorgina Barbara Piccoli
Gianfranca Cabiddu
Maria Rita Moio
Antioco Fois
Riccardo Cao
Ida Molfino
Ana Kaniassi
Francoise Lippi
Ludivine Froger
Antonello Pani
Marilisa Biolcati
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0948-8

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.